End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.64 CNY | +1.07% | -6.06% | -32.26% |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company benefits from high valuations in earnings multiples.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-32.26% | 434M | - | ||
+9.80% | 34.16B | C | ||
+24.97% | 8.13B | C- | ||
+30.03% | 4.44B | B- | ||
-28.70% | 2.7B | C- | ||
-20.62% | 1.37B | B | ||
-28.50% | 1.27B | - | C+ | |
-32.48% | 1.18B | - | ||
+12.29% | 1B | C | ||
-37.86% | 870M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- 688246 Stock
- Ratings Goodwill E-Health Info Co., Ltd.